Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Using genetic analysis to individualize preventive measures for breast and ovarian cancers

Nature Clinical Practice Oncology volume 3, pages 182–183 (2006)Cite this article

boxed-textNelson HD et al. (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 143: 362–379

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. U.S. Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 143: 355–361

  2. Parkin DM et al. (2005) Global cancer statistics. CA Cancer J Clin 55: 74–108

    Article  Google Scholar 

  3. National Comprehensive Cancer Network. (online 2 November 2005) Breast Cancer Risk Reduction. Clinical Practice Guidelines in Oncology. [www.nccn.org/professionals/physician_gls/PDF/breast.pdf] (accessed 21 December 2005)

  4. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 with breast cancer and 101,986 women without the disease. Lancet 538: 1389–1399

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of the Center for Clinical Cancer Genetics at the University of Chicago, Chicago, IL, USA

    Olufunmilayo I Olopade

Authors
  1. Olufunmilayo I Olopade
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olufunmilayo I Olopade.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olopade, O. Using genetic analysis to individualize preventive measures for breast and ovarian cancers. Nat Rev Clin Oncol 3, 182–183 (2006). https://doi.org/10.1038/ncponc0456

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0456

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing